158 Rotterdam, 160 Gordelweg, 3038 GE ROTTERDAM The Netherlands T h e conversion of the C21 steroids, 17-0H-Preqenolone and 17-0H-Proqesterone (17-OH-P) to the C19 sterolds DHEA: androstendione is mediated by the enzyme 17-20 desmolase. I t w a s recently suqqested that thls enzyme deficiency i s part of multiple abnormalities of steroid Llosynthetlc microsoma1,mixed fcnction oxidases. We present a Jewlsh lnfant 46xy who was with micropallus at birth (lcm) with glandular hypospadias and normal testis. T h e child grew normally with normal blood pressure and no salt wasting Ultrasonography: mullerlan duct derivatives absent. T h e child w a s raised a s male. After treatment with IICG and t-estosterone (TI the penis size increased (ilcm) . Hormonal findings: basal levels of cortisol ( F ) , high basal levels o f proqesterone (PI and 17-OH-P, and low basal levels of DllEA and T. P and 17-OM-P responded excessively to Case history: The mothcr of a boy with classical 21-OHD was treated with Dexamethason (DXM) 2 x 0.5 mg pcr day during her second pregnancy. Therapy was started 5 wks aftcr the last mcnstruation.Chorlon villus sampling in the 9th week of gestation rcvealed the sex of the fetus to be fcmale. Thc pattern of restriction fragmcnt length polymorphism for thc histocompatibility complex showed an Identical A and B region in the chorion villus materlal both in the fetus and in the affected boy (A19.26;B27.40). DXM was continued until dellvery. A nonvirilised girl was born. Salt loosing becamc apparent on the third day of life. Hormoridl evaluation confirmcd thc diagnosis of classical 21-OHD (17n OH-Progesterone 560 nmol/l; 114A 3 0 nmol/l; T 6.5 nmol/l). Glucocorticoid and mineraLocorticoid treatment was introduced. Conclusion: DXM given during pregnancy prevented iernale pseudohermaphroditism in a girl with classical salt looslng 21-OHD. Chorion villus sampllng is a useful technique to determine in an carly stage of gestation, the HLA pattern of the fetus. This tcchnique may be an adjunct In decisions as to whether to contlnue or discontinue the profylactic DXM therapy. ?hen, a partlal receptor deficiency is express%? In dlfferrnt pherwtyplc way in these t m siblings wlth XY caryoslxe the one was mintened m the ferale sex and the other in the d e sex. In this latter, nonrallzation of external genitalia was obkned with 1% tern androgen therapy which is eqlained by the rrrrurkablc raise of receptor-sites observed at 5 years ink-wall. action of testosterone (T) is known. Most, but not all, can bc traced back to either a functionally deficient receptor or a befect in the 5-alpha reductase activity. Thc current (in vitro) diagnostic approach involves cell culture of genital skin derived fibroblasts followcd by studies of whole cell dihydrotestosterone (DHT) or R1881 uptake and the kinctics of T reduction. Several receptor abnormalities can be detected only under spccial conditions: lability at 42'~; increased dissociation rate of the Lndrogcn rcceptor complex; different bchaviour in the absence of molybdate, etc. A more or less complcte investigation is therefore extremely time consuming, while in a significant percentage of all patients with the clinical diagnosis AIS, the diaqnosis cannot be confirmed or excluded by means of laboratory studies. Therefore, we tried a functional approach: fib5yblasts were stimulated for 6 days with T and DHT, followed by S-methionine pulse-labeling. Fabaled proteins were separated by means of 1-and 2-dimensional clcctrophoresis and detected by autoradiography. We found no evidence for the induction of new proteins, but the results suggest that under thcsc conditions in normal androgen-responsive cells at least one protein disappears. In AIS patients no such repression was seen. This functional approach 1s able to corroborate and cornplcment the "classical" reccptor studies.
J. BATI'IN and Ch. SOLTAK Clinique dfs Waladies dcs Enfants
N. L a~o r g i a~, A. Acquafredda", L . Piacente,':, A. A TL! ycars old girl with clitoral hypertrophy, palpable testes in labia majora and prepubertal aspect of breast, pubic land axillary hair was evaluated. Her karyotype was 46 XY. Bone age was 9 years. Basal and peak FSH (34 and 104 mU/ml) and LH (10 and 49 mU/ml) were evaluatcd during a GnRH tcst. Testoste-'rone levels (T), before and after HCG test (1000 U.I. every other day f o~ 5 days), wcrc 27 and 208 ngldl, respectively; basal Estradiol, 170HP and Cortisol during ACTH test and,TStl, T3 and T4 during TRH tcst were in the normal range. Gcnitography revealed the presence of rudimentary utcrus with a right tube. Histologic examination of removed testes showed bilaterally normal prepubertal testes. Neither ovarian nor dysplastic tissuc was found. Two months after surgery, basal and peak FSH (37 and 103 mU/ml) and LH (11 and 62 mU/ml) levels persisted elevated during GnRH test; T ( 4 1 5 ng/dl) did not risc aftcr HCG. This is the first report of incomplete tcsticular feminization with persistance of Mullerian structures probably due to a defective synthesis of MIF or some impairment of its action. Elcvatcd FSH values, already reported in some cascs of prepubertal TF, could be due to a dccrcascd production of Inhibin. Partial androgen resistance is characterized by varying degrees of ambiguous genitalia and the risk of virilization during puberty. The differentiation from other forms of PHR can be difficult. Attempts have been made to use biologic responses to exogenous testosterone as a test for androgen sensitivity, bearing the risk of undesired virilization of the phenotypically female infant. Androgens are known to suppress SHBG. Since in the testicular feminization syndrome not only the androgenic, but also the anabolic response is abolished, we investigated the effect of the anabolic steroid stanozolol on the SHBG-levels in plasma. Stanozolol was administered orally during 10 days ( 0.2 mg/kg U P to max. 10 mg/dose) to 9 control subjects, 2 patients with complete and 3 patients with incomplete androgen insensivity. In the control subjects the SHBG-levels decreased dramatically irrespective of sex and age: 51.7% t_ 3.5 [SD) of the initial values after 7 days, 39.6% after 10 days and 31.9% t 7.0 (SD) after two weeks. In thepatients with complete androgen insensivity the SHBG-levels remained unchanged, the moderate decrease in partial resistance was significantly different from the controls. Clinical effects or side effects of the stanozolol medication were not noted. We conclude that the detection of the SHBG-decrease following anabolic steroid administration seems to be a reliable, safe and simple test of androgen Sensitlvity.
